Company Filing History:
Years Active: 2020
Title: Joerg Sedelmeier: Innovator in NEP Inhibitor Synthesis
Introduction
Joerg Sedelmeier is a notable inventor based in Weil am Rhein, Germany. He has made significant contributions to the field of chemical synthesis, particularly in the development of neprilysin (NEP) inhibitors. His work is crucial in advancing therapeutic options for various medical conditions.
Latest Patents
Sedelmeier holds a patent for "Processes and intermediates for NEP inhibitor synthesis." This invention relates to a new chemical synthesis, intermediates, and catalysts useful for the preparation of the NEP inhibitor sacubitril, among others, via nitro 5 compounds. The patent also introduces new intermediate compounds and their applications in this innovative chemical synthesis route, along with a new catalyst ligand. He has 1 patent to his name.
Career Highlights
Joerg Sedelmeier is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on groundbreaking projects that aim to improve patient outcomes through innovative drug development.
Collaborations
Throughout his career, Sedelmeier has collaborated with talented professionals, including Florian Karl Kleinbeck-Riniker and Ives Mafli. These collaborations have fostered a creative environment that enhances the development of new therapeutic solutions.
Conclusion
Joerg Sedelmeier's contributions to NEP inhibitor synthesis exemplify the impact of innovative thinking in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.